| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.099 | 0.4 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |